Pancreatic enzyme replacement therapy for quality of life in chronic or recurrent acute pancreatitis

You may qualify if

• ≥ 18 years of age
• RAP (≥ 2 documented lifetime attacks with ≥ 2 of 3 acute pancreatitis criteria) OR Chronic pancreatitis (Cambridge I or II with documented history of AP OR Cambridge III or IV criteria)
• Fecal elastase ≥ 50 within the preceding 12 months

You can't join if

• Allergy/Intolerance to PERT/MBT
• Taking medications that alter fat absorption or that supplement the fatty acids being studied (e.g. orlistat, ursodeoxycholic acid, Fatty-15 fatty acid supplement etc.)
• Taking GLP-1 Receptor Agonist therapy
• Fecal elastase <50 within preceding 12 months OR pre-existing diagnosis of severe Exocrine Pancreatic Insufficiency, or ongoing steatorrhea
• Receiving Pancreatic Enzyme Replacement Therapy for > 5 days within the preceding 30 days
• Acute Pancreatitis attack (documented and meeting at least 2 of 3 criteria) within the preceding 90 days
• History of pancreatic resection or underlying malabsorptive disease
• Pregnant or Breast Feeding
• Other significant medical condition as judged by Principal Investigator